A detailed history of Blue Barn Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Blue Barn Wealth, LLC holds 3,382 shares of ABT stock, worth $398,264. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,382
Previous 3,390 0.24%
Holding current value
$398,264
Previous $352,000 9.38%
% of portfolio
0.21%
Previous 0.21%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$100.07 - $118.13 $800 - $945
-8 Reduced 0.24%
3,382 $385,000
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $20,045 - $22,375
199 Added 6.24%
3,390 $352,000
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $42,603 - $47,053
389 Added 13.88%
3,191 $362,000
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $25,794 - $31,574
-286 Reduced 9.26%
2,802 $308,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $3,439 - $4,126
36 Added 1.18%
3,088 $299,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $9,372 - $10,442
-93 Reduced 2.96%
3,052 $332,000
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $105,867 - $124,612
1,093 Added 53.27%
3,145 $318,000
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $54,374 - $63,789
-572 Reduced 21.8%
2,052 $225,000
Q3 2022

Oct 26, 2022

BUY
$96.76 - $112.03 $44,993 - $52,093
465 Added 21.54%
2,624 $254,000
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $114,216 - $138,051
-1,119 Reduced 34.14%
2,159 $235,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $27,250 - $33,230
239 Added 7.86%
3,278 $388,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $6,238 - $7,638
-54 Reduced 1.75%
3,039 $428,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $360,829 - $399,182
3,093 New
3,093 $365,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Blue Barn Wealth, LLC Portfolio

Follow Blue Barn Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Barn Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blue Barn Wealth, LLC with notifications on news.